Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Rocz Akad Med Bialymst ; 50: 208-11, 2005.
Article in English | MEDLINE | ID: mdl-16358968

ABSTRACT

PURPOSE: The aim of the study was to estimate the anthropometric parameters and their relationship to serum levels of IGF-I, IGF-II, IGFBP-3, IGFBP-2 and leptin before and during intensive antineoplastic treatment for acute lymphoblastic leukaemia in children. MATERIAL AND METHODS: In 46 children in median age 6.6 years (range from 1.6 to 16) we evaluated at the time of diagnosis, after protocol I and after intensive treatment, height, body mass index (BMI) and IGF-I, IGF-II, IGFBP-3, IGFBP-2 and leptin. RESULTS: Height SDS lowered in successive points of analysis whereas BMI SDS rose after protocol II. IGF-I SDS was low and similar at each point, IGF-II SDS and IGFBP-3 SDS values augmented progressively and IGFBP-2 SDS was significantly elevated before treatment and lowered (but not normalized) during the therapy. Leptin SDS was elevated, especially after protocol I. CONCLUSION: Leukaemia and its treatment affect directly growth factors, its binding proteins and leptin production leading to growth retardation and overweight.


Subject(s)
Body Constitution , Growth Disorders/drug therapy , Insulin-Like Growth Factor Binding Protein 2/blood , Insulin-Like Growth Factor Binding Protein 3/blood , Insulin-Like Growth Factor II/metabolism , Insulin-Like Growth Factor I/metabolism , Leptin/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Adolescent , Antineoplastic Agents/therapeutic use , Body Height , Child , Child, Preschool , Female , Growth Disorders/blood , Humans , Infant , Male , Overweight , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL